We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:9000L
GW Pharmaceuticals PLC
04 June 2003
GW Pharmaceuticals plc
Notice of Interim Results
GW Pharmaceuticals plc, the company licensed by the UK Home Office to work with
cannabis and a range of controlled drugs for medical research purposes, will be
announcing its interim results for the six months ended 31 March 2003 on
Thursday 19 June 2003.
An analyst meeting will be held on the day. Please contact Cass Helstrip for
further information.
Enquiries:
Weber Shandwick Square Mile 020 7067 0738
Cass Helstrip
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORKZLBBXQBZBBL
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
